Tumor expression of cyclin-dependent kinase 5 (Cdk5) is a prognostic biomarker and predicts outcome of oxaliplatin-treated metastatic colorectal cancer patients

Autor: Ruiz de Porras, V., Bystrup, Sara, Cabrero de las Heras, Sara, Musulén, Eva, Palomero, L., Alonso, M. H., Nieto Raya, Rocio, Arango, Diego, Moreno, V., Queralt, C., Manzano Mozo, José Luís, Layos, Laura, Bugés, Cristina, Martínez Balibrea, Eva, Universitat Autònoma de Barcelona

Publikováno v: Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Scientia
Cancers, Vol 11, Iss 10, p 1540 (2019)
Dipòsit Digital de la UB
Universidad de Barcelona
Cancers
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Volume 11
Issue 10

Colorectal cancer; Cyclin-dependent kinase 5 (Cdk5); Prognostic and predictive biomarker Cáncer colorrectal; Quinasa dependiente de ciclina 5 (Cdk5); Biomarcador pronóstico y predictivo Càncer colorectal; Quinasa dependent de ciclina 5 (CDK5); Bio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56efa9325119a6d543b07b201a358f4f
https://ddd.uab.cat/record/222858

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tumor Expression of Cyclin-Dependent Kinase 5 (Cdk5) Is a Prognostic Biomarker and Predicts Outcome of Oxaliplatin-Treated Metastatic Colorectal Cancer Patients.

Autor: Ruiz de Porras V; Program of predictive and personalized cancer medicine (PMPPC) Germans Trias i Pujol Research Institute (IGTP), Ctra. Can Ruti-Camí de les escoles s/n, 08916 Badalona, Spain. vruiz@igtp.cat.; Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology, Ctra. Can Ruti- Camí de les escoles s/n, 08916 Badalona, Spain. vruiz@igtp.cat., Bystrup S; Program of predictive and personalized cancer medicine (PMPPC) Germans Trias i Pujol Research Institute (IGTP), Ctra. Can Ruti-Camí de les escoles s/n, 08916 Badalona, Spain. sbystrup@igtp.cat.; Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology, Ctra. Can Ruti- Camí de les escoles s/n, 08916 Badalona, Spain. sbystrup@igtp.cat., Cabrero-de Las Heras S; Program of predictive and personalized cancer medicine (PMPPC) Germans Trias i Pujol Research Institute (IGTP), Ctra. Can Ruti-Camí de les escoles s/n, 08916 Badalona, Spain. scabrero@igtp.cat.; Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology, Ctra. Can Ruti- Camí de les escoles s/n, 08916 Badalona, Spain. scabrero@igtp.cat., Musulén E; Department of Pathology, Hospital Universitari Germans Trias i Pujol, Ctra. Can Ruti-Camí de les escoles s/n, 08916 Badalona, Spain. emusulen@hotmail.com.; Department of Pathology, Hospital Universitari General de Catalunya, Grupo Quirónsalud, Pedro i Pons 1, 08195 Sant Cugat del Valles, Spain. emusulen@hotmail.com., Palomero L; Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology, 08908 L'Hospitalet del Llobregat, Barcelona, Spain. lpalomero@iconcologia.net.; ONCOBELL Program, Bellvitge Institute for Biomedical Research, 08908 L'Hospitalet del Llobregat, Barcelona, Spain. lpalomero@iconcologia.net., Alonso MH; ONCOBELL Program, Bellvitge Institute for Biomedical Research, 08908 L'Hospitalet del Llobregat, Barcelona, Spain. mhalonso@iconcologia.net.; Oncology Data Analytics Program, Institut Català d'Oncologia (ICO), 08908 Barcelona, Spain. mhalonso@iconcologia.net.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain. mhalonso@iconcologia.net.; Department of Clinical Sciences, Faculty of Medicine and Health Sciences, University of Barcelona, 08907 Barcelona, Spain. mhalonso@iconcologia.net., Nieto R; Group of Biomedical Research in Digestive Tract Tumors, CIBBIM-Nanomedicine, Vall d'Hebron University Hospital, Research Institute (VHIR), Universitat Autònoma de Barcelona, Passeig Vall d'Hebron, 119-129, 08035 Barcelona, Spain. rocio.nieto@vhir.org., Arango D; Group of Biomedical Research in Digestive Tract Tumors, CIBBIM-Nanomedicine, Vall d'Hebron University Hospital, Research Institute (VHIR), Universitat Autònoma de Barcelona, Passeig Vall d'Hebron, 119-129, 08035 Barcelona, Spain. diego.arango@vhir.org., Moreno V; ONCOBELL Program, Bellvitge Institute for Biomedical Research, 08908 L'Hospitalet del Llobregat, Barcelona, Spain. v.moreno@iconcologia.net.; Oncology Data Analytics Program, Institut Català d'Oncologia (ICO), 08908 Barcelona, Spain. v.moreno@iconcologia.net.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain. v.moreno@iconcologia.net.; Department of Clinical Sciences, Faculty of Medicine and Health Sciences, University of Barcelona, 08907 Barcelona, Spain. v.moreno@iconcologia.net., Queralt C; Program of predictive and personalized cancer medicine (PMPPC) Germans Trias i Pujol Research Institute (IGTP), Ctra. Can Ruti-Camí de les escoles s/n, 08916 Badalona, Spain. cqueralt@iconcologia.net.; Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology, Ctra. Can Ruti- Camí de les escoles s/n, 08916 Badalona, Spain. cqueralt@iconcologia.net., Manzano JL; Program of predictive and personalized cancer medicine (PMPPC) Germans Trias i Pujol Research Institute (IGTP), Ctra. Can Ruti-Camí de les escoles s/n, 08916 Badalona, Spain. jmanzano@iconcologia.net.; Medical Oncology Service, Catalan Institute of Oncology (ICO), 08908, Spain. jmanzano@iconcologia.net.; B-ARGO group, Germans Trias I Pujol Research Institute (IGTP), Ctra. Can Ruti- Camí de les escoles s/n, 08916 Badalona, Spain. jmanzano@iconcologia.net., Layos L; Program of predictive and personalized cancer medicine (PMPPC) Germans Trias i Pujol Research Institute (IGTP), Ctra. Can Ruti-Camí de les escoles s/n, 08916 Badalona, Spain. llayos@iconcologia.net.; Medical Oncology Service, Catalan Institute of Oncology (ICO), 08908, Spain. llayos@iconcologia.net.; B-ARGO group, Germans Trias I Pujol Research Institute (IGTP), Ctra. Can Ruti- Camí de les escoles s/n, 08916 Badalona, Spain. llayos@iconcologia.net., Bugés C; Program of predictive and personalized cancer medicine (PMPPC) Germans Trias i Pujol Research Institute (IGTP), Ctra. Can Ruti-Camí de les escoles s/n, 08916 Badalona, Spain. cbuges@iconcologia.net.; Medical Oncology Service, Catalan Institute of Oncology (ICO), 08908, Spain. cbuges@iconcologia.net.; B-ARGO group, Germans Trias I Pujol Research Institute (IGTP), Ctra. Can Ruti- Camí de les escoles s/n, 08916 Badalona, Spain. cbuges@iconcologia.net., Martinez-Balibrea E; Program of predictive and personalized cancer medicine (PMPPC) Germans Trias i Pujol Research Institute (IGTP), Ctra. Can Ruti-Camí de les escoles s/n, 08916 Badalona, Spain. embalibrea@iconcologia.net.; Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology, Ctra. Can Ruti- Camí de les escoles s/n, 08916 Badalona, Spain. embalibrea@iconcologia.net.

Publikováno v: Cancers [Cancers (Basel)] 2019 Oct 11; Vol. 11 (10). Date of Electronic Publication: 2019 Oct 11.